BioMimetic Therapeutics
Franklin
About BioMimetic Therapeutics
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $59.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2009)
- Ticker: nasdaq:BMTI
- Website: biomimetics.com
- Phone: 615-844-1280
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biomimetic-therapeutics-3286345 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.